Kelly Kimberly A, Allport Jennifer R, Tsourkas Andrew, Shinde-Patil Vivek R, Josephson Lee, Weissleder Ralph
Center for Molecular Imaging Research, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
Circ Res. 2005 Feb 18;96(3):327-36. doi: 10.1161/01.RES.0000155722.17881.dd. Epub 2005 Jan 13.
Endothelial vascular adhesion molecule-1 (VCAM-1) is a critical component of the leukocyte-endothelial adhesion cascade, and its strict temporal and spatial regulation make it an ideal target for imaging and therapy. The goal of this study was to develop novel VCAM-1-targeted imaging agents detectable by MRI and fluorescence imaging using phage display-derived peptide sequences and multimodal nanoparticles (NPs). We hypothesized that VCAM-1-mediated cell internalization of phage display-selected peptides could be harnessed as an amplification strategy to chaperone and trap imaging agents inside VCAM-1-expressing cells, thus improving target-to-background ratios. To accomplish our goal, iterative phage display was performed on murine endothelium under physiological flow conditions to identify a family of VCAM-1-mediated cell-internalizing peptides. One specific sequence, containing the VHSPNKK motif that has homology to the alpha-chain of very late antigen (a known ligand for VCAM-1), was shown to bind VCAM-1 and block leukocyte-endothelial interactions. Compared with VCAM-1 monoclonal antibody, the peptide showed 12-fold higher target-to-background ratios. A VHSPNKK-modified magnetofluorescent NP (VNP) showed high affinity for endothelial cells expressing VCAM-1 but surprisingly low affinity for macrophages. In contrast, a control NP without VCAM-1-targeting sequences showed no affinity for endothelial cells. In vivo, VNP successfully identified VCAM-1-expressing endothelial cells in a murine tumor necrosis factor-alpha-induced inflammatory model and colocalized with VCAM-1-expressing cells in atherosclerotic lesions present in cholesterol-fed apolipoprotein E apoE-/- mice. These results indicate that: (1) small peptide sequences can significantly alter targeting of NPs, (2) the used amplification strategy of internalization results in high target-to-background ratios, and (3) this technology is useful for in vivo imaging of endothelial markers.
内皮血管黏附分子-1(VCAM-1)是白细胞-内皮细胞黏附级联反应的关键组成部分,其严格的时空调节使其成为成像和治疗的理想靶点。本研究的目的是利用噬菌体展示衍生的肽序列和多模态纳米颗粒(NPs)开发可通过磁共振成像(MRI)和荧光成像检测的新型靶向VCAM-1的成像剂。我们假设,VCAM-1介导的噬菌体展示选择肽的细胞内化可作为一种放大策略,用于陪伴和捕获成像剂于表达VCAM-1的细胞内,从而提高靶本比。为实现我们的目标,在生理流动条件下对小鼠内皮细胞进行迭代噬菌体展示,以鉴定一系列VCAM-1介导的细胞内化肽。一个特定序列,包含与极晚期抗原α链具有同源性的VHSPNKK基序(极晚期抗原是已知的VCAM-1配体),显示可结合VCAM-1并阻断白细胞-内皮细胞相互作用。与VCAM-1单克隆抗体相比,该肽的靶本比高12倍。一种VHSPNKK修饰的磁荧光纳米颗粒(VNP)对表达VCAM-1的内皮细胞显示出高亲和力,但对巨噬细胞的亲和力出人意料地低。相比之下,没有VCAM-1靶向序列的对照纳米颗粒对内皮细胞没有亲和力。在体内,VNP在小鼠肿瘤坏死因子-α诱导的炎症模型中成功识别出表达VCAM-1的内皮细胞,并与喂食胆固醇的载脂蛋白E缺陷(apoE-/-)小鼠动脉粥样硬化病变中表达VCAM-1的细胞共定位。这些结果表明:(1)小肽序列可显著改变纳米颗粒的靶向性;(2)所采用的内化放大策略可导致高靶本比;(3)该技术可用于内皮标志物的体内成像。